Finance

Lists
Why is TEVA up 5.00%?
Dive Deeper
TEVA:TLV
Teva Pharmaceutical Industries Limited
ILA 12,600.00
+5.00%
(+600.00) 1D
10-р сарын 12, 15:28:02 (GMT+3)  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for TEVA...
Open
ILA 12,610.00
High
ILA 12,640.00
Low
ILA 12,550.00
Mkt. cap
146.77Т
Avg. vol.
1.05 сая
Volume
733.84 мян
P/E ratio
68.61
52-wk high
ILA 12,640.00
52-wk low
ILA 6,207.00
EPS
ILA 1.84
Shares outstanding
1.17 тэрбум
No. of employees
32 мян
Open
ILA 12,610.00
High
ILA 12,640.00
Low
ILA 12,550.00
Mkt. cap
146.77Т
Avg. vol.
1.05 сая
Volume
733.84 мян
P/E ratio
68.61
52-wk high
ILA 12,640.00
52-wk low
ILA 6,207.00
EPS
ILA 1.84
Shares outstanding
1.17 тэрбум
No. of employees
32 мян
News stories
From web sources and news partners
Profile
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs. Wikipedia
About Teva Pharmaceutical Industries Limited
CEORichard Francis
Employees32 мян
Founded1944 оны 2-р сарын 13
Headquarters-
SectorPharmaceutical industry
Websiteteva.co.il
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
4.48 тэрбум
4.71 тэрбум
3.98 тэрбум
4.14 тэрбум
Cost of goods sold
2.18 тэрбум
2.06 тэрбум
2.01 тэрбум
1.99 тэрбум
Cost of revenue
2.18 тэрбум
2.06 тэрбум
2.01 тэрбум
1.99 тэрбум
Research and development expenses
256.00 сая
267.00 сая
222.00 сая
970.00 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
973.00 сая
1.12 тэрбум
1.00 тэрбум
1.03 тэрбум
Operating expense
1.24 тэрбум
1.37 тэрбум
1.21 тэрбум
1.99 тэрбум
Total operating expenses
3.41 тэрбум
3.43 тэрбум
3.22 тэрбум
3.98 тэрбум
Operating income
1.07 тэрбум
1.28 тэрбум
763.00 сая
167.00 сая
Other non operating income
-27.00 сая
-
-13.00 сая
-69.00 сая
EBT including unusual items
648.00 сая
90.00 сая
436.00 сая
-455.00 сая
EBT excluding unusual items
832.00 сая
1.08 тэрбум
547.00 сая
-57.00 сая
Income tax expense
214.00 сая
-390.00 сая
67.00 сая
121.00 сая
Effective tax rate
33.02%
-433.33%
15.37%
-26.59%
Other operating expenses
9.00 сая
-17.00 сая
-14.00 сая
-18.00 сая
Net income
433.00 сая
480.00 сая
369.00 сая
-576.00 сая
Net profit margin
9.67%
10.19%
9.27%
-13.91%
Earnings per share
0.78
0.96
0.53
0.02
Interest and investment income
-
92.00 сая
-
-
Interest expense
-205.00 сая
-280.00 сая
-191.00 сая
-186.00 сая
Net interest expenses
-205.00 сая
-188.00 сая
-191.00 сая
-186.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
1.32 тэрбум
1.54 тэрбум
1.00 тэрбум
408.00 сая
Gain or loss from assets sale
-
-
-8.00 сая
-12.00 сая
AI content may include mistakes. Learn more
Google аппс